The data marks a fundamental turning point in the prevention of melanoma recurrences, a disease where avoiding relapse and ...

The Tumaini Ebola vaccine trial in Congo began in Bunia on 23 October 2026, testing Ervebo against the Bundibugyo strain amid ...

Merck & Co. and Moderna always knew they would be making headlines in Madrid this week—just not in the way it panned out. | Merck & Co. and Moderna always knew they would be making headlines in Madrid ...

The article argues that Shingrix’s widely marketed “90% effective” figure is a relative risk reduction that obscures a low ...

Drugs targeting the protein Wee1 looked promising, but an incomplete understanding of their mechanism likely led to the ...

Until now, the flu shot lineup featured six vaccination options —using live viruses, inactivated viruses or viral antigens—delivered via needle injection or nasal spray. The mRNA vaccine has proven ...

A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system ...

Conflicting reports suggest Mr. Hurts was hospitalized and advised to stay awake until kickoff as a safety precaution. He ...

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma ...

This week, one of Robert F. Kennedy Jr.’s most malevolent plots was finally brought to a halt when police in Guinea-Bissau ...

Six melanoma specialists described Moderna and Merck's personalized cancer vaccine results as clinically meaningful and ...